- Home
- ALDX vs NCTY Comparison
ALDX vs NCTY Comparison
Compare ALDX & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- NCTY
- Stock Information
- Founded
- ALDX 2004
- NCTY 1999
- Country
- ALDX United States
- NCTY China
- Employees
- ALDX N/A
- NCTY N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- NCTY Business Services
- Sector
- ALDX Health Care
- NCTY Consumer Discretionary
- Exchange
- ALDX Nasdaq
- NCTY Nasdaq
- Market Cap
- ALDX 133.7M
- NCTY 156.7M
- IPO Year
- ALDX 2014
- NCTY 2004
- Fundamental
- Price
- ALDX $2.15
- NCTY $9.36
- Analyst Decision
- ALDX Strong Buy
- NCTY
- Analyst Count
- ALDX 2
- NCTY 0
- Target Price
- ALDX $9.50
- NCTY N/A
- AVG Volume (30 Days)
- ALDX 1.2M
- NCTY 89.6K
- Earning Date
- ALDX 05-14-2025
- NCTY 01-01-0001
- Dividend Yield
- ALDX N/A
- NCTY N/A
- EPS Growth
- ALDX N/A
- NCTY N/A
- EPS
- ALDX N/A
- NCTY N/A
- Revenue
- ALDX N/A
- NCTY $15,305,175.00
- Revenue This Year
- ALDX N/A
- NCTY N/A
- Revenue Next Year
- ALDX N/A
- NCTY N/A
- P/E Ratio
- ALDX N/A
- NCTY N/A
- Revenue Growth
- ALDX N/A
- NCTY N/A
- 52 Week Low
- ALDX $1.14
- NCTY $5.75
- 52 Week High
- ALDX $7.20
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- ALDX 38.93
- NCTY 32.45
- Support Level
- ALDX $2.15
- NCTY $11.21
- Resistance Level
- ALDX $2.30
- NCTY $11.95
- Average True Range (ATR)
- ALDX 0.15
- NCTY 0.75
- MACD
- ALDX 0.06
- NCTY -0.21
- Stochastic Oscillator
- ALDX 37.93
- NCTY 8.21
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.